A vs BCAB · P/E 29, rev $1.88B vs $5.9M cap
Agilent Technologies Inc (A) versus Bioatla Inc (BCAB) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
A currently screens at market cap $33.70B and trailing P/E 29.2. BCAB currently screens at market cap $5.9M.
Not investment advice. Open the A and BCAB stock pages for the full models.
Not investment advice.